CARE Program for Postpartum Mental Health

(PMAD-CARE Trial)

No longer recruiting at 1 trial location
OJ
AZ
Overseen ByAmanda Zayde, Psy.D.
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Montefiore Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a group therapy program called the Connecting and Reflecting Experience (CARE) to determine its effectiveness for parents with postpartum mood or anxiety disorders, such as postpartum depression. The researchers aim to assess whether the program is likable, feasible, and beneficial for mental health, reducing parenting stress, and enhancing the bond with their baby. Eligibility includes those who have given birth in the last 3 to 12 months, are receiving postpartum care at Montefiore Medical Center, and have experienced postpartum depression or anxiety. Participants will attend 12 group therapy sessions and complete surveys about their experiences. As an unphased trial, this study offers a unique opportunity to contribute to innovative mental health solutions for postpartum parents.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on group therapy, so you may not need to change your medication routine, but it's best to confirm with the trial organizers.

What prior data suggests that the CARE parenting program is safe for postpartum parents with PMADs?

Research shows that the Connecting and Reflecting Experience (CARE) parenting program is safe and well-received. Parents and caregivers of older children with mental health issues find it helpful and appealing. Although researchers have not specifically tested it for new parents with mood and anxiety disorders, the program's focus on improving parent-child relationships has succeeded in other groups. No reports link negative effects directly to the CARE program, making it a promising choice for those seeking to enhance mental health and parenting skills.12345

Why are researchers excited about this trial?

Researchers are excited about the CARE Program for postpartum mental health because it offers a fresh approach through group therapy specifically designed for new parents. Unlike traditional treatments such as medication or one-on-one therapy sessions, the CARE Program facilitates a supportive community environment where participants can connect and reflect on their experiences as new parents. This communal setting aims to provide emotional support and shared understanding, which can be particularly beneficial for addressing the unique challenges of postpartum mental health. The program emphasizes the power of collective healing and shared experiences, which makes it a promising alternative or complement to existing treatment options.

What evidence suggests that the CARE Program is effective for postpartum mental health?

Research has shown that the Connecting and Reflecting Experience (CARE) program, which participants in this trial will receive, has been helpful for parents and caregivers of older children with mental health issues. Although it has not been specifically tested with new parents dealing with postpartum mood and anxiety disorders (PMADs), the program's focus on helping parents understand and manage their own and their children's emotions appears promising. This approach can strengthen parent-child relationships and reduce stress for parents. Early findings suggest that programs like CARE can be appealing and useful, making them worth considering for postpartum mental health challenges.23467

Who Is on the Research Team?

AZ

Amanda Zayde, Psy.D.

Principal Investigator

Montefiore Medical Center/Albert Einstein College of Medicine

Are You a Good Fit for This Trial?

This trial is for postpartum parents who have given birth within the last 3-12 months, are English-speaking, and are currently receiving care at Montefiore Medical Center. It's aimed at those experiencing moderate to high levels of depression or anxiety after childbirth. Parents already in a CARE group or another parenting program, with severe mental health issues needing intense treatment, or current psychosis/mania can't participate.

Inclusion Criteria

English-speaking
I am a parent of a baby aged 3-12 months.
Receiving postpartum OB/GYN or mental health services at Montefiore Medical Center
See 1 more

Exclusion Criteria

You are currently experiencing severe mental health symptoms like hallucinations or extreme mood swings.
You have mental health, memory, or substance abuse problems that require more intense care than just visiting a doctor, such as being in the hospital.
Prior participation in a Connecting and Reflecting Experience (CARE) group at any time
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 12-session CARE parenting group therapy program

15 weeks
12 sessions (in-person or virtual)

Follow-up

Participants are monitored for changes in mental health, parenting stress, and parent-infant bonding after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Connecting and Reflecting Experience (CARE) Program
Trial Overview The study tests the Connecting and Reflecting Experience (CARE) Program—a group therapy designed to improve mental health, reduce parenting stress, and strengthen parent-infant relationships among postpartum parents with mood/anxiety disorders. Participants will attend 12 sessions and complete surveys to assess the program's impact on their well-being.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Connecting and Reflecting Experience (CARE) ProgramExperimental Treatment1 Intervention

Connecting and Reflecting Experience (CARE) Program is already approved in United States for the following indications:

🇺🇸
Approved in United States as Connecting and Reflecting Experience (CARE) Program for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Montefiore Medical Center

Lead Sponsor

Trials
468
Recruited
599,000+

American Psychological Foundation

Collaborator

Trials
20
Recruited
2,200+

Published Research Related to This Trial

Thirteen states have implemented policies aimed at improving peripartum mental health, including mandates for depression screening and public awareness campaigns.
Despite these policies, evidence suggests they have a limited impact on clinical outcomes for postpartum depression, indicating a need for more effective interventions like home visits that include mental health support.
State mandates regarding postpartum depression.Rowan, PJ., Duckett, SA., Wang, JE.[2015]
A multidisciplinary health service intervention program significantly improved postpartum mental health in women, as indicated by a lower Edinburgh Postnatal Depression Scale (EPDS) score in the intervention group compared to the control group (2.74 vs. 4.58, p < 0.001).
The intervention group also had higher engagement in health services, with more women receiving counseling, attending maternal seminars, and receiving home visits from public health nurses, demonstrating the program's effectiveness in enhancing access to care.
Integrated mental health care in a multidisciplinary maternal and child health service in the community: the findings from the Suzaka trial.Tachibana, Y., Koizumi, N., Akanuma, C., et al.[2020]
A new outpatient psychotherapeutic treatment program has been developed specifically for mothers experiencing acute postpartum mental illness, addressing their unique needs during the perinatal period.
Empirical results suggest that this outpatient program is an effective alternative to hospitalization, allowing mothers to receive necessary treatment without being separated from their children.
Outpatient psychotherapy for mothers--a new treatment.Kersting, A., Fisch, S., Arolt, V.[2018]

Citations

1.samhsa.govsamhsa.gov/
Home | SAMHSA - Substance Abuse and Mental Health ...SAMHSA leads efforts to advance behavioral health across the U.S., offering resources for mental health, substance use, and community well-being.
Consequences of maternal postpartum depressionPPD is also defined symptomatically as exceeding a given threshold on a screening measure, such as the Edinburgh Postnatal Depression Scale (EPDS). In general, ...
A Family-Based Collaborative Care Model for Treatment of ...The FBCCM includes the following two components: (1) a 10-session video-delivered family therapy treatment for perinatal depression and anxiety ...
A Postpartum Adaptation Study of the Connecting and ...Experiencing postpartum mood and/or anxiety disorders (like postpartum depression; PMADs) can make parenting challenging, but group therapy ...
Postpartum Depression and Maternal Care: Exploring the ...Postpartum depression (PPD) is a common and debilitating mental health condition affecting many mothers worldwide. This review article aims ...
“Insight at a Cost”: Postpartum Depressed Mothers' ...The Circle of Security-Parenting (COSP™) program is an American psychoeducational intervention designed to improve parental sensitive ...
Positive Parenting Can Reduce Risk for Postpartum ...A recent study investigated the effectiveness of two pediatric primary care interventions for reducing the risk for postpartum depressive symptoms.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security